The Pharmaceutical Supply Chain Management (SCM) Market is anticipated to experience substantial growth from 2025 to 2033, fuelled by the Increasing outsourcing of drug manufacturing and reliance on global suppliers (APIs, raw materials) require integrated and robust SCM systems to manage complex global networks and mitigate risks like delays or shortages. With an estimated valuation of approximately USD 4.1 billion in 2025, the market is expected to reach USD 9.7 billion by 2033, registering a robust compound annual growth rate (CAGR) of 11.6% over the decade.